Invest Liverpool City Region
World Famous, Word Leading
An innovative study has been launched at the Royal Liverpool University Hospital to explore how a new antimicrobial coating can protect the NHS by reducing healthcare associated infections (HAIs) HAIs are a risk to patients, visitors and staff, and cover a range of different infections including methicillin-resistant Staphylococcus aureus (MRSA) and Clostridioides difficile (C. difficile). …
Continuing to move through a pipeline of health and life science investment, LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation, has announced its latest investment in emerging biotech, Daresbury Proteins. Continuing to move through a pipeline of health and life science investment, LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation, has announced its …
The Clatterbridge Cancer Centre has secured another high-profile status – this time in a collaboration with London’s Royal Marsden Hospital. After an exacting process, Clatterbridge has now become part of a Biomedical Research Centre (BRC) in its partnership with The Royal Marsden, one of the most prestigious cancer centres in the world. Achieving BRC status …
